North America Autotransfusion Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type, Application, and End User and Country

According to a new market research study of “North America Autotransfusion Devices Forecast to 2027 - COVID-19 Impact and Global Analysis by Type, Application and End-User, the North America Autotransfusion Devices is projected to reach US$ 426.31 million by 2027 from US$ 305.15 million in 2019. The market is estimated to grow at CAGR of 4.4% from 2020 to 2027. The report highlights trends prevailing in the North America Autotransfusion Devices market and the factors driving market along with those that act as hindrances.

Based on type, the North America Autotransfusion Devices market is further segmented into products and accessories. The product segment held the largest share of the market in 2019. However, the Accessories segment is estimated to register the highest CAGR in the market during the forecast period. The autotransfusion products comprises a system that operates in combination with various components, such as wash kits, vacuum pump, transfer bags, and others. Autotransfusion products are easy to use, and a few are fully automated. For example, the autoLog autotransfusion system by Medtronic is fully automated. It operates in a two-stage filling cycle-the initial stage and final stage. This two-stage processing helps in the smooth transition of blood flow during the process. The system is fitted with a level sensor that controls and monitors the red cell pack level. The product segment is further categorized into intraoperative autotransfusion system, postoperative autotransfusion system, dual mode autotransfusion system.

North America Autotransfusion Devices market is expected to grow owing to factors such as growth include involvement of rare blood groups, rising number of transplant procedures and rising prevalence of chronic diseases. Whereas, the market is likely to have negative impact due to the, risks associated with autotransfusion.

Zimmer Biomet, BD, Teleflex Incorporated, Fresenius SE & Co. KGaA, Medtronic, are among the leading companies operating in the North America Autotransfusion Devices market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America autotransfusion devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America autotransfusion devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Autotransfusion Devices Market - by Product
1.3.2 North America Autotransfusion Devices Market- by Application
1.3.3 North America Autotransfusion Devices Market - by Country

2. North America Autotransfusion Devices Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Autotransfusion Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 PEST Analysis
4.3.1 North America- PEST Analysis
4.4 Expert Opinion

5. North America Autotransfusion Devices Market Key Market Dynamics

5.1 Key Market Drivers
5.2 Market Drivers
5.2.1 Growing Incidences of Chronic Pain
5.2.2 Market Player Initiatives
5.3 Market Restraints
5.3.1 High Cost of Pain Management Devices
5.4 Opportunities
5.4.1 Growth Demand for Neurostimulation Devices
5.5 Trends
5.5.1 Technological Advancement
5.6 Impact Analysis

6. Autotransfusion Devices Market - North America Analysis

6.1 North America Autotransfusion Devices Market Revenue Forecasts and Analysis

7. Autotransfusion Devices Market Analysis - by Product Type

7.1 Overview
7.2 Autotransfusion Devices Market Share, by Product Type, 2019 and 2027 (%)
7.3 Neuromodulation Devices
7.3.1 Overview
7.3.2 Neuromodulation Devices: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
7.3.3.1 Overview
7.3.3.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
7.3.4 Spinal Cord Stimulation (SCS) Devices
7.3.4.1 Overview
7.3.4.2 Spinal Cord Stimulation (SCS) Devices: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Ablation Devices
7.4.1 Overview
7.4.2 Ablation Devices: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3 Radiofrequency Ablation Devices
7.4.3.1 Overview
7.4.3.2 Radiofrequency Ablation Devices: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
7.4.4 Cryoablation Devices
7.4.4.1 Overview
7.4.4.2 Cryoablation Devices: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Analgesic Infusion Pumps
7.5.1 Overview
7.5.2 Analgesic Infusion Pumps: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
7.5.3 Intrathecal Infusion Pumps
7.5.3.1 Overview
7.5.3.2 Intrathecal Infusion Pumps: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
7.5.4 External Infusion Pumps
7.5.4.1 Overview
7.5.4.2 External Infusion Pumps: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)

8. Autotransfusion Devices Market Analysis - by Application

8.1 Overview
8.2 Autotransfusion Devices Market Share, by Application, 2019 and 2027 (%)
8.3 Neuropathic Pain
8.3.1 Overview
8.3.2 Neuropathic Pain: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Facial Pain and Migraine
8.4.1 Overview
8.4.2 Facial Pain and Migraine: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Musculoskeletal Pain
8.5.1 Overview
8.5.2 Musculoskeletal Pain: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Cancer Pain
8.6.1 Overview
8.6.2 Cancer Pain: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)

9. Autotransfusion Devices Market - Geographic Analysis

9.1 North America: Autotransfusion Devices Market
9.1.1 Overview
9.1.2 North America: Autotransfusion Devices Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Autotransfusion Devices Market, by Product Type, 2018-2027 (USD Million)
9.1.3.1 North America: Neuromodulation Devices, Market, by Type, 2018-2027 (USD Million)
9.1.3.2 North America: Ablation Devices Market, by Type, 2018-2027 (USD Million)
9.1.3.3 North America: Analgesic Infusion Pumps Market, by Type, 2018-2027 (USD Million)
9.1.4 North America: Autotransfusion Devices Market, by Application, 2018-2027 (USD Million)
9.1.5 North America: Autotransfusion Devices Market, by Country, 2019 & 2027 (%)
9.1.5.1 US: Autotransfusion Devices Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.1.1 US: Autotransfusion Devices Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.1.2 US: Autotransfusion Devices Market, by Product Type, 2018-2027 (USD Million)
9.1.5.1.2.1 US: Neuromodulation Devices, Market, by Type, 2018-2027 (USD Million)
9.1.5.1.2.2 US: Ablation Devices Market, by Type, 2018-2027 (USD Million)
9.1.5.1.2.3 US: Analgesic Infusion Pumps Market, by Type, 2018-2027 (USD Million)
9.1.5.1.3 US: Autotransfusion Devices Market, by Application, 2018-2027 (USD Million)
9.1.5.2 Canada: Autotransfusion Devices Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.2.1 Canada: Autotransfusion Devices Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.2.2 Canada: Autotransfusion Devices Market, by Product Type, 2018-2027 (USD Million)
9.1.5.2.2.1 Canada: Neuromodulation Devices, Market, by Type, 2018-2027 (USD Million)
9.1.5.2.2.2 Canada: Ablation Devices Market, by Type, 2018-2027 (USD Million)
9.1.5.2.2.3 Canada: Analgesic Infusion Pumps Market, by Type, 2018-2027 (USD Million)
9.1.5.2.3 Canada: Autotransfusion Devices Market, by Application, 2018-2027 (USD Million)
9.1.5.3 Mexico: Autotransfusion Devices Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.3.1 Mexico: Autotransfusion Devices Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.3.2 Mexico: Autotransfusion Devices Market, by Product Type, 2018-2027 (USD Million)
9.1.5.3.2.1 Mexico: Neuromodulation Devices, Market, by Type, 2018-2027 (USD Million)
9.1.5.3.2.2 Mexico: Ablation Devices Market, by Type, 2018-2027 (USD Million)
9.1.5.3.2.3 Mexico: Analgesic Infusion Pumps Market, by Type, 2018-2027 (USD Million)
9.1.5.3.3 Mexico: Autotransfusion Devices Market, by Application, 2018-2027 (USD Million)

10. Impact of COVID-19 Pandemic on North America Autotransfusion Devices Market

10.1 North America: Impact Assessment of COVID-19 Pandemic

11. Company Profiles

11.1 BD
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Medtronic
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Boston Scientific Corporation
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Abbott
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Pfizer Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments

12. Appendix

12.1 About the Publisher
12.2 Glossary of Terms

List of Tables

Table 1. North America Autotransfusion Devices Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 2. North America Autotransfusion Devices Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 3. North America Autotransfusion Devices Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 4. US Autotransfusion Devices Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 5. US Autotransfusion Devices Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 6. US Autotransfusion Devices Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Autotransfusion Devices Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Autotransfusion Devices Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Autotransfusion Devices Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Autotransfusion Devices Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Autotransfusion Devices Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Autotransfusion Devices Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 1. Glossary of Terms, North America Autotransfusion Devices Market

List of Figures

Figure 1. Autotransfusion Devices Market Segmentation
Figure 2. North America Autotransfusion Devices Market Overview
Figure 3. Injectable Drug Delivery Segment Held Largest Share of Product Segment in Autotransfusion Devices Market
Figure 4. US is Expected to show Remarkable Growth during the Forecast Period
Figure 5. North America Autotransfusion Devices Market - Leading Country Markets (US$ Mn)
Figure 7. North America Autotransfusion Devices Market - North America PEST Analysis
Figure 8. Autotransfusion Devices Market Impact Analysis of Drivers and Restraints
Figure 9. North America Autotransfusion Devices Market - Revenue Forecasts and Analysis-2019-2027
Figure 10. North America Autotransfusion Devices Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 11. Oral Drug Delivery: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Injectable Drug Delivery: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Topical Drug Delivery: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Ocular Drug Delivery: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Pulmonary Drug Delivery: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Nasal Drug Delivery: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Transmucosal Drug Delivery: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Implantable Drug Delivery: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. North America Autotransfusion Devices Market Revenue Share, by Application (2019 and 2027)
Figure 20. Infectious Diseases: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cancer: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Cardiovascular Diseases: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Diabetes: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Respiratory Diseases: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Central Nervous Systems Disorders: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Autoimmune Diseases: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Other Diseases: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. North America Autotransfusion Devices Market Share, by End User, 2019 and 2027 (%)
Figure 29. Hospitals: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Home Care Settings: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. ASCs/ Clinics: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Other End Users: Autotransfusion Devices Market - Revenue and Forecast to 2027 (US$ Million)
Figure 33. North America: Autotransfusion Devices Market, by Key Country - Revenue (2019) (USD Million)
Figure 34. North America Autotransfusion Devices Market Revenue and Forecast to 2027 (USD Million)
Figure 35. North America: Autotransfusion Devices Market, by Country, 2019 & 2027 (%)
Figure 36. US: Autotransfusion Devices market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Canada: Autotransfusion Devices Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Mexico: Autotransfusion Devices Market - Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in North American Country Markets